Abbott loses president and restructures top management
This article was originally published in Clinica
Abbott Laboratories is setting up a new management structure to tie in with the retirement of its president and chief operating officer, Robert Parkinson, after less than two years in the job. The reorganisation is part of a long-term plan to provide greater strategic and scientific focus across the company's three divisions, Abbott said. Shares in the company rose 4% to $41.4 on the news.